产品详情
简单介绍：
Anti-NLRP11抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-NLRP11抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
详情介绍：
Rabbit Anti-NLRP11
Cat. Number:
Anti-NLRP11抗体KL-19283R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
NALPs are cytoplasmic proteins that form a subfamily within the larger CATERPILLER protein family. Most short NALPs, such as NALP11, have an N-terminal pyrin (MEFV; MIM 608107) domain (PYD), followed by a NACHT domain, a NACHT-associated domain (NAD), and a C-terminal leucine-rich repeat (LRR) region. The long
Anti-NLRP11抗体NALP, NALP1 (MIM 606636), also has a C-terminal extension containing a function to find domain (FIIND) and a caspase recruitment domain (CARD). NALPs are implicated in the activation of proinflammatory caspases (e.g., CASP1; MIM 147678) via their involvement in multiprotein complexes called inflammasomes (Tschopp et al., 2003 [PubMed 12563287]).[supplied by OMIM, Mar 2008]
Also known as:
CLR19.6; FLJ26273; NACHT leucine rich repeat and PYD containing 11; NACHT LRR and PYD domains containing protein 11;
Anti-NLRP11抗体NACHT, LRR and PYD domains-containing protein 11; NAL11_HUMAN; NALP11; NLR family pyrin domain containing 11; NLRP11; NOD17; Nucleotide binding oligomerization domain protein 17; Nucleotide-binding oligomerization domain protein 17; Nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain containing 11; PAAD and NACHT containing protein 10B; PAAD and NACHT domain containing protein 10; PAAD-and NACHT domain-containing protein 10; PAN10; PYPAF6; PYPAF7; PYRIN containing APAF1 like protein 6; PYRIN-containing APAF1-like protein 6.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, .
●
Immunogen: KLH conjugated synthetic
Anti-NLRP11抗体peptide derived from human NLRP11.
●
Predicted Molecular Weight: 118kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-NLRP11抗体
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-NLRP11抗体
Optimal working dilutions must be determined by the end user.
